MegaSyn, a Hesse-wide research initiative, funded by the Hessen State Ministry of Higher Education, Research and the Arts, which focuses on the understanding of megasynthases in structure and function, and controlling megasynthases for directed product synthesis. The MegaSyn research program includes 12 groups from 5 different institutions.

MegaSyn Logo

The design of single proteins and complete biosynthetic pathways currently establishes as important tool in molecular life sciences. Driven by the increasing understanding in the structure and function of proteins and their complex interplay, possibilities arise to use natural systems (proteins, protein cascades, and microorganisms) for the directed and sustainable synthesis of biomolecules; thereby complementing traditional synthetic chemistry. Such approaches, aiming at developing “green” and “bioeconomic” synthetic methods, are of high sociopolitical importance. The research focus MegaSyn is concentrating on the biosynthetic production of technologically and pharmaceutically valuable compounds, as organic acids, antibiotics and immunosuppressives, which are synthesized by fatty acid synthases (FAS), polyketide synthases (PKS) and non-ribosomal peptide synthetases (NRPS). Megasynthases are gigantic multifunctional enzymes that covalently link small carbon- and amino acid units in an assembly like concept similarly as found in car manufacturing processes. Intermediates are bound to the megasynthase during synthesis until they are released in the final step as mature natural compound. MegaSyn is based on two synergistic developments, to which members of MegaSyn have substantially contributed during the last years; the newly established knowledge on the function and manipulation of FAS, PKS and NRPS megasynthases, and new and improved methods in structural biology, which were essential to pave the way for handling these complex proteins.


F.A.Q on MegaSyn.


What is MegaSyn?

MegaSyn is a LOEWE collaborative research project from the State of Hessen.

What is the key question addressed by MegaSyn?

Can the unique synthetic principle of megasynthases be employed for the production of antibiotics and other drugs via biomimetic approaches?

Who is involved in MegaSyn?

MegaSyn brings together scientific expertise from five research institutions. Goethe University Frankfurt leads the team, which includes as partners the MPI of Biophysics in Frankfurt, Philipps University Marburg, the MPI for Terrestrial Microbiology in Marburg and the Technische Hochschule Mittelhessen in Gießen.

What is the basic concept of MegaSyn?

MegaSyn will concentrate on the biosynthetic production of technologically and pharmaceutically valuable compounds such as organic acids, antibiotics and immunosuppressives, which are synthesized by fatty acid synthases (FAS), polyketide synthases (PKS) or non-ribosomal peptide synthetases (NRPS).

What makes MegaSyn a unique research focus?

MegaSyn identified model megasynthases, which will shall be engineered for the custom synthesis of technologically and pharmaceutically valuable compounds. In doing so, MegaSyn is different to most initiatives in the field, which aim for discovering such compound from native (“non-engineered”) sources.

Who are the contact persons of MegaSyn?

Please look at contact page. We welcome your feedback.